SCHEMBL14981978

SCHEMBL14981978

CCOC(=O)/C=C/C(=O)N(O)CCCN(C)Cc1ccc(COC(=O)Nc2ccc(N(C)C)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
MAPT P10636 5/20 0.43
KDM4E B2RXH2 3/20 0.43
NPC1 O15118 3/20 0.43
HPGD P15428 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
RAB9A P51151 2/20 0.43
MAPK1 P28482 2/20 0.43
MCL1 Q07820 1/20 0.43
NAMPT P43490 1/20 0.38
KDM6B O15054 1/20 0.38
KDM4A O75164 1/20 0.38
EGLN2 Q96KS0 1/20 0.38
EGLN1 Q9GZT9 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
EGLN3 Q9H6Z9 1/20 0.38
HIF1AN Q9NWT6 1/20 0.38
PHF8 Q9UPP1 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14981979 0.90 KDM4E (0.47) ALDH1A1MAPTKDM4ENPC1HPGD
SCHEMBL14985131 0.87 KDM4E (0.50) ALDH1A1MAPTKDM4ENPC1HPGD
SCHEMBL14981982 0.87 NAMPT (0.42) ALDH1A1MAPTNPC1SMN1; SMN2RAB9A
SCHEMBL14981981 0.82 KDM4E (0.45) ALDH1A1MAPTKDM4ENPC1HPGD
SCHEMBL14981980 0.80 ALDH1A1 (0.40) ALDH1A1MAPTKDM4ENPC1HPGD
SCHEMBL14985124 0.79 KDM4E (0.55) ALDH1A1MAPTKDM4ENPC1HPGD
SCHEMBL14985104 0.76 KDM4E (0.61) ALDH1A1MAPTKDM4ENPC1HPGD
SCHEMBL14985125 0.76 KDM4E (0.65) ALDH1A1MAPTKDM4ENPC1HPGD
SCHEMBL14981983 0.74 KDM6B (0.46) KDM4ENPC1HPGDSMN1; SMN2RAB9A
SCHEMBL14981975 0.74 KDM4E (0.62) ALDH1A1KDM4ENPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735622-B2 Histone demethylase inhibitors and methods for using the same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2014-05-27 US disclosed
US-8735622-B2 Histone demethylase inhibitors and methods for using the same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2014-05-27 US disclosed
US-20130137720-A1 HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME The Regents of the University of Colorado, a body corporated (US) 2013-05-30 US disclosed
US-20130137720-A1 HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME The Regents of the University of Colorado, a body corporated (US) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137720-A1 HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME KDM1A, KDM3A, KDM7A ALDH1A1 837/4885MAPT 2972/4885KDM4E 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.